CAR T-Cell Therapy for Non-Hodgkin Lymphoma | Cancer Q&A — Discussing Common Questions Posed by Patients
Hematologic Oncology Update
00:00
Barriers to referral and access
Jeremy outlines logistical, socioeconomic, and travel barriers that limit patients from receiving CAR T.
Play episode from 08:54
Transcript
